Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

Cell

Volumn 96, Issue 1, 1999, Pages 35-45

  Willis, Tony G ^a   Jadayel, Dalal M ^a   Du, Ming Qing ^b   Peng, Huaizheng ^b   Perry, Amanda R ^a   Abdul Rauf, Munah ^a   Price, Helen ^a   Karran, Loraine ^a   Majekodunmi, Oluwatosin ^a   Wlodarska, Iwona ^c   Pan, Langxing ^b   Crook, Tim ^a   Hamoudi, Rifat ^a   Isaacson, Peter G ^a   Dyer, Martin J S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 14; FRAMESHIFT MUTATION; GENE SEQUENCE; GENETIC LINKAGE; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE HOMOLOGY;

EQUIDAE; EQUINE HERPESVIRUS 1; EQUINE HERPESVIRUS 2; HERPESVIRIDAE; HERPESVIRUS 2;

EID: 0033534627     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80957-5     Document Type: Article

References (45)

1. Cattoretti, G., Chang, C.C., Cechova, K., Zhang, J., Ye, B.H., Falini, B., Louie, D.C., Offit, K., Chaganti, R.S.K., and Dalla-Favera, R. (1995). BCL-6 protein is expressed in germinal-center B cells. Blood 86, 45-53.
2. Chou, J.J., Matsuo, H., Duan, H., and Wagner, G. (1998). Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 94, 171-180.
3. Colussi, P.A., Harvey, N.L., and Kumar, S. (1998). Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J. Biol. Chem. 273, 24535-24542.
4. Crook, T., Marston, N.J., Sara, E.A., and Vousden, K.H. (1994). Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79, 817-827.
5. Duan, H., and Dixit, V.M. (1997). RAIDD is a new 'death' adaptor molecule. Nature 385, 86-89.
6. Eliyahu, D., Michalovitz, D., and Oren, M. (1985). Overproduction of p53 antigen makes established cells highly tumorigenic. Nature 316, 158-160.
7. Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., and Oren, M. (1989). Wild type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA 86, 8763-8767.
8. Gualberto, A., Aldape, K., Kozakiewicz, K., and Tlsty, T.D. (1998). An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl. Acad. Sci. USA 95, 5166-5171.
9. Gutierrez, M.I., Spangler, G., Kingma, D., Raffeld, M., Guerrero, I., Misad, O., Jaffe, E.S., Magrath, I.T., and Bhatia, K. (1998). Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. Blood 92, 600-606.
10. Hofmann, K., Bucher, P., and Tschopp, J. (1997). The CARD domain: a new apoptotic signaling motif. Trends Biochem. Sci. 22, 155-156.
11. Hussell, T., Isaacson, P.G., and Spencer, J. (1993). Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosaassociated lymphoid tissue in vitro. J. Pathol. 169, 221-227.
12. Inohara, N., del Peso, L, Koseki, T., Chen, S., and Nunez, G. (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273, 12296-12300.
13. Isaacson, P.G., and Spencer, J. (1995). The biology of low-grade MALT lymphomas. J. Clin. Pathol. 48, 395-397.
14. Jain, V.K., Judde, J.G., Max, E.E., and Magrath, I.T. (1993). Variable IgH enhancer activity in Burkitt's lymphomas suggests an additional direct mechanism of c-myc deregulation. J. Immunol. 150, 5418-5428.
15. Koseki, T., Inohara, N., Chen, S., and Nunez, G. (1998). ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc. Natl. Acad. Sci. USA 95, 5156-5160.
16. Lee, W.C., Balsara, B., Liu, Z., Jhanwar, S.C, and Testa, J.R. (1996). Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res. 56, 4297-4301.
17. McCarthy, J.V., Ni, J., and Dixit, V.M. (1998). RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J. Biol. Chem. 273, 16968-16975.
18. Magrath, I.T. (1990). The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55, 133-270.
19. Mathew, S., Murty, V.V., Bosl, G.J., and Chaganti, R.S.K. (1994). Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res. 54, 6265-6269.
20. Matolcsy, A., Casali, P., Warnke, R.A., and Knowles, D.M. (1996) Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bel-2 gene. Blood 88, 3937-3944.
21. Mayo, M.W., Wang, C.Y., Cogswell, P.C., Rogers-Graham, K.S., Lowe, S.W., Der, C.J., Baldwin, A.S., Jr. (1997). Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812-1815.
22. Mertens, F., Johansson, B., Hoglund, M., and Mitelman, F. (1997). Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res. 57, 2765-2780.
23. Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B.H., Knowles, D.M., Offit, K., Chaganti, R.S., and Dalla-Favera, R. (1995). Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc. Natl. Acad. Sci. USA 92, 12520-12524.
24. Pan, L., Diss, T.C., Peng, H., and Isaacson, P.G. (1997). Immersionhisto polymerase chain reaction: a practical tool for the visualisation of single copy genes in tissue sections. Am. J. Pathol. 150, 1245-1252.
25. Parker, G.A., Crook, T., Bain, M., Sara, E.A., Farrell, P.J., and Allday, M.J. (1996). Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13, 2541-2549.
26. Peng, H., Du, M., Diss, T.C., Isaacson, P.G., and Pan, L. (1997). Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma. Histopathology 30, 425-429.
27. Rabbitts, T.H., Hamlyn, P.H., and Baer, R. (1983). Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature 306, 760-765.
28. Reuther, J.Y., Reuther, G.W., Cortez, D., Pendergast, A.M., and Baldwin, A.S., Jr. (1998). A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev. 12, 968-981.
29. Schneider, J.F., Fisher, F., Goding, C.R., and Jones, N.C. (1987). Mutational analysis of the adenovirus E1 a gene: the role of transcriptional regulation in transformation. EMBO J. 6, 2053-2060.
30. Shen, H.M., Peters, A., Baron, B., Zhu, X., and Storb, U. (1998). Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750-1752.
31. Shih, C., and Weinberg R.A. (1982). Isolation of a transforming sequence from a human carcinoma cell line. Cell 29, 161-169.
32. Telford, E.A.R., Watson, M.S., Aird, H.C., Perry, J., and Davison, A.J. (1995). The DNA sequence of Equine Herpesvirus 2. J. Mol. Biol. 249, 520-528.
33. Thangavelu, M., Finn, W.G., Yelavarthi, K.K., Roenigk, H.H., Jr., Samuelson, E., Peterson, L, Kuzel, T.M., and Rosen, S.T. (1997). Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides Sezary syndrome. Blood 89, 3371-3377.
34. Thome, M., Hofmann, K., Burns, K., Martinen, F., Bodmer, J.L, Mattmann, C., and Tschopp, J. (1998). Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 16, 885-888.
35. Tilly, H., Rossi, A., Stamatoullas, A., Lenormand, B., Bigorgne, C., Kunlin, A., Monconduit, M., and Bastard, C. (1994). Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84, 1043-1049.
36. Tsujimoto, Y., Finger, L.R., Yunis, J., Nowell, P.C., and Croce, C.M. (1984). Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226, 1097-1099.
37. Vaandrager, J.W., Schuuring, E., Zwikstra, E., de Boer, C.J., Kleiverda, K.K., van Krieken, J.H., Kluin-Nelemans, H.C., van Ommen, G.J., Raap, A.K., and Kluin, P.M. (1996). Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 88, 1177-1182.
38. Van Antwerp, D.J., Martin, S.J., Verma, I.M., and Green, D.R. (1998). Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell. Biol. 8, 107-111.
39. Willis, T.G., Jadayel, D.M., Coignet, L.J.A., Abdul-Rauf, M., Treleaven, J.G., Catovsky, D., and Dyer, M.J.S. (1997). Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood 90, 2456-2464.
40. Willis, T.G., Zalcberg, I.R., Coignet, L.J., Wlodarska, I., Stul, M., Jadayel, D.M., Bastard, C., Treleaven, J.G., Catovsky, D., Silva, M.L.M., and Dyer, M.J.S. (1998). Molecular cloning of translocation t(1:14)(q21:q32) defines a novel gene (BCL9) at chromosome 1q21. Blood 91, 1873-1881.
41. Wotherspoon, A.C., Pan, L, Diss, T.C., and Isaacson, P.G. (1992). Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoma tissue. Cancer Genet. Cytogenet. 58, 35-38.
42. Wotherspoon, A.C., Doglioni, C., Diss, T.C., Pan, L, Moschini, A., de Boni, M., and Isaacson, P.G. (1993). Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-577.
43. Wu, M., Lee, H., Bellas, R.E., Schauer, S.L., Arsura, M., Katz, D., FitzGerald, M.J., Rothstein, T.L., Sherr, D.H., and Sonenshein, G.E. (1996). Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15, 4682-4690.
44. Yin, C., Knudson, C.M., Korsmeyer, S.J., and Van Dyke, T. (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-640.
45. Zutter, M., Hockenbery, D., Silverman, G.A., and Korsmeyer, S.J. (1991). Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 78, 1062-1068.